4//SEC Filing
Kantoff Philip W. 4
Accession 0001842952-22-000059
CIK 0001842952other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:10 PM ET
Size
5.4 KB
Accession
0001842952-22-000059
Insider Transaction Report
Form 4
Kantoff Philip W.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-02+25,000→ 25,000 totalExercise: $2.19Exp: 2032-06-01→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001866025
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:10 PM ET
- Size
- 5.4 KB